This is the original version (as it was originally made). This item of legislation is currently only available in its original format.
44. In regulation 41(c) (application and effect of manufacturing authorisation), before “the premises,” insert “except in the case of an MM investigational medicinal product or a POC investigational medicinal product,”.
All content is available under the Open Government Licence v3.0 except where otherwise stated. This site additionally contains content derived from EUR-Lex, reused under the terms of the Commission Decision 2011/833/EU on the reuse of documents from the EU institutions. For more information see the EUR-Lex public statement on re-use.
